Contributors

Maria A. Blasco, Ph.D. Department of Immunology and Oncology (DIO), National Centre of Biotechnology, Madrid, Spain

W. Ted Brown, M.D., Ph.D., F.A.C.M.G. Department of Human Genetics, New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, U.S.A.

Judith Campisi, Ph.D. Department of Cell and Molecular Biology, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, U.S.A.

David J. Chen, Ph.D. Department of Cell and Molecular Biology, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, U.S.A.

Leslie Colvin, M.Sc., C.G.C. Provincial Medical Genetics Programme, Department of Medical Genetics, University of British Columbia/Children's and Women's Health Centre, Vancouver, British Columbia, Canada

Martin Digweed, Ph.D. Institute of Human Genetics, Charité-Campus Vir-chow, Humboldt-Universität zu Berlin, Berlin, Germany

Nathan A. Ellis, Ph.D. Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York, U.S.A.

Maria I. Fousteri, Ph.D. Department of Radiation Genetics and Chemical Mutagenesis, Leiden University Medical Center, Leiden, The Netherlands

Eberhard Fritz, Ph.D. Institute of Molecular Radiation Biology, GSF-National Research Center for Environment and Health, Neuherberg, Germany

Yasuhiro Furuichi, Ph.D. GeneCare Research Institute Co., Ltd., Kamakura, Kanagawa, Japan

David Gilley, Ph.D. Department of Cell and Molecular Biology, Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, U.S.A.

Jack D. Griffith, Ph.D. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, U.S.A.

Michaela Thiel Gross, Ph.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

Martina Guttenbach, Ph.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

Philip S. Hartman, Ph.D. Department of Biology, Texas Christian University, Fort Worth, Texas, U.S.A.

Nina S. Heiss, Ph.D.* Department of Molecular Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ) (German Cancer Research Center), Heidelberg, Germany

Doug Hinerfeld, Ph.D. Buck Institute for Age Research, Novato, California, U.S.A.

Fuki M. Hisama, M.D. Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.

Holger Hoehn, M.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

*Current affiliation: Oncology Research, Merck KgaA, Darmstadt, Germany

Bruce H. Howard, M.D. Laboratory of Molecular Growth Regulation, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland, U.S.A.

Peng Hu, Ph.D. Cell Biology Program, Memorial Sloan-Kettering Cancer Center, New York, New York, U.S.A.

Naoaki Ishii Department of Molecular Life Science, Tokai University School of Medicine, Isehara, Kanagawa, Japan

Thomas E. Johnson, Ph.D. Institute for Behavioral Genetics, University of Colorado at Boulder, Boulder, Colorado, U.S.A.

Stania B. Jurenka Willow Clinic, British Columbia Ministry for Children and Families, New Westminster, British Columbia, Canada

Saori Kitao, Ph.D. Department of Target Discovery, GeneCare Research Institute Co., Ltd., Kamakura, Kanagawa, Japan

Alan R. Lehmann, Ph.D. Genome Damage and Stability Centre, School of Biological Sciences, University of Sussex, Brighton, United Kingdom

Robert A. Marciniak, M.D., Ph.D. Departments of Medicine and Cellular and Structural Biology, University of Texas Health Science Center, San Antonio, Texas, U.S.A.

George M. Martin, M.D. Department of Pathology, University of Washington, Seattle, Washington, U.S.A.

Birgit Maurer, M.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

Simon Melov, Ph.D. Buck Institute for Age Research, Novato, California, U.S.A.

M. Stephen Meyn, M.D., Ph.D. Genetics and Genome Biology Program, The Hospital for Sick Children, University of Toronto, Toronto, Ontario, Canada

Junko Oshima, M.D., Ph.D. Department of Pathology, University of Washington, Seattle, Washington, U.S.A.

Annemarie Poustka, Ph.D. Department of Molecular Genome Analysis, Deutsches Krebsforschungszentrum (DKFZ) (German Cancer Research Center), Heidelberg, Germany

Enrique Samper Department of Immunology and Oncology (DIO), National Centre of Biotechnology, Madrid, Spain

Detlev Schindler, M.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

Michael Schmid, Ph.D. Department of Human Genetics, University of Würzburg, Würzburg, Germany

Jerry W. Shay, Ph.D. Department of Cell Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, U.S.A.

Akira Shimamoto, Ph.D. Department of Target Discovery, GeneCare Research Institute Co., Ltd., Kamakura, Kanagawa, Japan

Alexandra Sobeck, Ph.D. Department of Molecular Medicine, Oregon Health and Science University, Portland, Oregon, U.S.A.

Rachel M. Stansel, Ph.D. Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, U.S.A.

Poornima K. Tekumalla, Ph.D. Department of Neurology, Yale University School of Medicine, New Haven, Connecticut, U.S.A.

John Tower, Ph.D. Molecular and Computational Biology Program, Department of Biological Sciences, University of Southern California, Los Angeles, California, U.S.A.

Margot I. Van Allen, M.D. Department of Medical Genetics, University of British Columbia/Children's and Women's Health Centre, Vancouver, British Columbia, Canada

Matthias Wagner, Ph.D. LYNKEUS BioTech GmbH, Würzburg, Germany

Sherman M. Weissman, M.D. Department of Genetics, Yale University School of Medicine, New Haven, Connecticut, U.S.A.

Woodring E. Wright, M.D., Ph.D. Department of Cell Biology, University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, U.S.A.

0 0

Post a comment